Novanta Inc (1GSN) - Total Liabilities
Based on the latest financial reports, Novanta Inc (1GSN) has total liabilities worth €704.34 Million EUR (≈ $823.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Novanta Inc - Total Liabilities Trend (2015–2024)
This chart illustrates how Novanta Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Novanta Inc to evaluate short-term liquidity relative to the company's equity base.
Novanta Inc Competitors by Total Liabilities
The table below lists competitors of Novanta Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GEPIC Energy Development Co Ltd
SHE:000791
|
China | CN¥20.06 Billion |
|
Cousins Properties Incorporated
NYSE:CUZ
|
USA | $4.55 Billion |
|
KONINKLIJKE VOP.UNSP.ADR
F:VPK
|
Germany | €3.54 Billion |
|
Suven Pharmaceuticals Limited
NSE:SUVENPHAR
|
India | Rs11.91 Billion |
|
ExlService Holdings Inc
NASDAQ:EXLS
|
USA | $897.58 Million |
|
Clear Secure Inc
NYSE:YOU
|
USA | $959.75 Million |
|
Sai MicroElectronics Inc
SHE:300456
|
China | CN¥1.87 Billion |
|
IPG Photonics Corporation
NASDAQ:IPGP
|
USA | $305.85 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Novanta Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Novanta Inc (1GSN) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Novanta Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Novanta Inc (2015–2024)
The table below shows the annual total liabilities of Novanta Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €642.81 Million ≈ $751.52 Million |
+16.33% |
| 2023-12-31 | €552.60 Million ≈ $646.04 Million |
-16.73% |
| 2022-12-31 | €663.63 Million ≈ $775.85 Million |
-6.08% |
| 2021-12-31 | €706.59 Million ≈ $826.08 Million |
+81.94% |
| 2020-12-31 | €388.37 Million ≈ $454.05 Million |
-14.18% |
| 2019-12-31 | €452.56 Million ≈ $529.09 Million |
+28.82% |
| 2018-12-31 | €351.32 Million ≈ $410.73 Million |
-15.38% |
| 2017-12-31 | €415.16 Million ≈ $485.36 Million |
+148.94% |
| 2016-12-31 | €166.77 Million ≈ $194.97 Million |
-2.67% |
| 2015-12-31 | €171.34 Million ≈ $200.32 Million |
-- |
About Novanta Inc
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets las… Read more